JP2008505075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008505075A5 JP2008505075A5 JP2007519246A JP2007519246A JP2008505075A5 JP 2008505075 A5 JP2008505075 A5 JP 2008505075A5 JP 2007519246 A JP2007519246 A JP 2007519246A JP 2007519246 A JP2007519246 A JP 2007519246A JP 2008505075 A5 JP2008505075 A5 JP 2008505075A5
- Authority
- JP
- Japan
- Prior art keywords
- tartrate
- phenylglycinyl
- piperidin
- indole
- piperazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58359904P | 2004-06-30 | 2004-06-30 | |
| PCT/US2005/020490 WO2006011955A1 (en) | 2004-06-30 | 2005-06-13 | 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008505075A JP2008505075A (ja) | 2008-02-21 |
| JP2008505075A5 true JP2008505075A5 (https=) | 2008-08-07 |
Family
ID=35276192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007519246A Pending JP2008505075A (ja) | 2004-06-30 | 2005-06-13 | １−（インドール−６−カルボニル−ｄ−フェニルグリシニル）−４−（１−メチルピペリジン−４−イル）ピペラジンｄ−酒石酸塩 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070249623A1 (https=) |
| EP (1) | EP1763521A1 (https=) |
| JP (1) | JP2008505075A (https=) |
| CN (1) | CN1984903A (https=) |
| AR (1) | AR049659A1 (https=) |
| AU (1) | AU2005267579A1 (https=) |
| BR (1) | BRPI0512245A (https=) |
| CA (1) | CA2570634A1 (https=) |
| EA (1) | EA010307B1 (https=) |
| EC (1) | ECSP067105A (https=) |
| IL (1) | IL179903A0 (https=) |
| MA (1) | MA28842B1 (https=) |
| MX (1) | MXPA06015112A (https=) |
| NO (1) | NO20070486L (https=) |
| PE (1) | PE20060480A1 (https=) |
| SV (1) | SV2006002156A (https=) |
| TW (1) | TW200603806A (https=) |
| WO (1) | WO2006011955A1 (https=) |
| ZA (1) | ZA200610091B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0616574D0 (en) * | 2006-08-21 | 2006-09-27 | Glaxo Group Ltd | Compounds |
| CN107365304A (zh) * | 2017-08-01 | 2017-11-21 | 齐宜涛 | 一种治疗心血管疾病的化合物及制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA51676C2 (uk) * | 1995-11-02 | 2002-12-16 | Пфайзер Інк. | (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція |
| GB9821058D0 (en) * | 1998-09-28 | 1998-11-18 | Univ Cardiff | Chemical compound |
| EP1163217B1 (en) * | 1999-03-15 | 2005-09-21 | Novo Nordisk A/S | New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| DE60022508T2 (de) * | 1999-06-14 | 2006-06-08 | Eli Lilly And Co., Indianapolis | Inhibitoren von serin proteasen |
| US6448293B1 (en) * | 2000-03-31 | 2002-09-10 | Pfizer Inc. | Diphenyl ether compounds useful in therapy |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0019228D0 (en) * | 2000-08-04 | 2000-09-27 | Smithkline Beecham Plc | Novel pharmaceutical |
| CA2447405C (en) * | 2001-05-14 | 2006-10-17 | Pfizer Products Inc. | Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| TWI257389B (en) * | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
-
2005
- 2005-06-13 BR BRPI0512245-7A patent/BRPI0512245A/pt not_active IP Right Cessation
- 2005-06-13 CN CNA2005800214090A patent/CN1984903A/zh active Pending
- 2005-06-13 EP EP05760368A patent/EP1763521A1/en not_active Withdrawn
- 2005-06-13 WO PCT/US2005/020490 patent/WO2006011955A1/en not_active Ceased
- 2005-06-13 CA CA002570634A patent/CA2570634A1/en not_active Abandoned
- 2005-06-13 JP JP2007519246A patent/JP2008505075A/ja active Pending
- 2005-06-13 EA EA200700186A patent/EA010307B1/ru not_active IP Right Cessation
- 2005-06-13 AU AU2005267579A patent/AU2005267579A1/en not_active Abandoned
- 2005-06-13 US US11/570,686 patent/US20070249623A1/en not_active Abandoned
- 2005-06-13 MX MXPA06015112A patent/MXPA06015112A/es not_active Application Discontinuation
- 2005-06-17 TW TW094120115A patent/TW200603806A/zh unknown
- 2005-06-27 PE PE2005000741A patent/PE20060480A1/es not_active Application Discontinuation
- 2005-06-29 AR ARP050102705A patent/AR049659A1/es unknown
- 2005-06-29 SV SV2005002156A patent/SV2006002156A/es not_active Application Discontinuation
-
2006
- 2006-12-01 ZA ZA200610091A patent/ZA200610091B/en unknown
- 2006-12-07 IL IL179903A patent/IL179903A0/en unknown
- 2006-12-20 EC EC2006007105A patent/ECSP067105A/es unknown
-
2007
- 2007-01-25 NO NO20070486A patent/NO20070486L/no not_active Application Discontinuation
- 2007-01-29 MA MA29641A patent/MA28842B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL189500A (en) | 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p | |
| JP2010513478A5 (https=) | ||
| TWI315203B (en) | Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments | |
| WO2007058602A3 (en) | Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. | |
| FI3281939T3 (fi) | Yhdistelmä, joka sisältää 4-oksokinoliiniyhdisteen stabiilin kiteen | |
| WO2007048066A3 (en) | Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators | |
| JP2010536849A5 (https=) | ||
| JP2008513510A5 (https=) | ||
| JP2007523135A5 (https=) | ||
| JP2009545527A5 (https=) | ||
| TW200738241A (en) | Pyridazine derivatives | |
| JP2012512885A5 (https=) | ||
| IL191310A (en) | A variant of the factor xa enhancer hemostasis, a pharmaceutical product containing it, and its use in the preparation of drugs for the treatment of hemostasis-related diseases | |
| UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
| ATE495747T1 (de) | Kristalline form des ibandronat-natriums und herstellungsverfahren dafür | |
| TW200716628A (en) | Novel compounds | |
| JP2010518061A5 (https=) | ||
| JP2009537554A5 (https=) | ||
| TW200722081A (en) | New therapeutic combinations for the treatment or prevention of depression | |
| JP2008516004A5 (https=) | ||
| IL187575A (en) | Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders | |
| TW200604196A (en) | New quinuclidine derivatives and pharmaceutical compositions comprising them | |
| JP2007119497A5 (https=) | ||
| JP2009532434A5 (https=) | ||
| IL206657A (en) | Transformed oxindole derivatives, the pharmaceutical compositions containing them and their use in the preparation of drugs for the treatment of vasopressin-dependent diseases |